Personalizing and targeting therapy for COPD – the role of molecular and clinical biomarkers

References

• Vestbo J, Hurd SS, Agustí AG et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 187(4), 347–365 (2013).
   PubMed Web of Science ®Google Scholar
• Lozano R, Naghavi M, Foreman K et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380(9859), 2095–2128 (2012).
   PubMed Web of Science ®Google Scholar
• Zeng G, Sun B, Zhong N. Non-smoking-related chronic obstructive pulmonary disease: a neglected entity? Respirology 17(6), 908–912 (2012).
   PubMed Web of Science ®Google Scholar
• Siedlinski M, Tingley D, Lipman PJ et al. Dissecting direct and indirect genetic effects on chronic obstructive pulmonary disease (COPD) susceptibility. Hum. Genet. 132(4), 431–441 (2013).
   PubMed Web of Science ®Google Scholar
• Drummond MB, Hansel NN, Connett JE, Scanlon PD, Tashkin DP, Wise RA. Spirometric predictors of lung function decline and mortality in early chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 185(12), 1301–1306 (2012).
   PubMed Web of Science ®Google Scholar
• Montuschi P. Drugs for chronic obstructive pulmonary disease. Curr. Med. Chem. 20(12), 1461–1463 (2013).
   PubMed Web of Science ®Google Scholar
• Montuschi P. Pharmacological treatment of chronic obstructive pulmonary disease. Int. J. Chron. Obstruct. Pulmon. Dis. 1(4), 409–423 (2006).
   PubMedGoogle Scholar
• Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet 379(9823), 1341–1351 (2012).
   PubMed Web of Science ®Google Scholar
• Rosenberg SR, Kalhan R. Biomarkers in chronic obstructive pulmonary disease. Transl. Res. 159(4), 228–237 (2012).
   PubMed Web of Science ®Google Scholar
• Montuschi P. Toward a personalized pharmacotherapy of respiratory diseases. Front. Pharmacol. 1, 131 (2010).
   PubMed Web of Science ®Google Scholar
• Bowman RV, Wright CM, Davidson MR, Francis SM, Yang IA, Fong KM. Epigenomic targets for the treatment of respiratory disease. Expert Opin. Ther. Targets 13(6), 625–640 (2009).
   PubMed Web of Science ®Google Scholar
• Wan ES, Qiu W, Baccarelli A et al. Cigarette smoking behaviors and time since quitting are associated with differential DNA methylation across the human genome. Hum. Mol. Genet. 21(13), 3073–3082 (2012).
   PubMed Web of Science ®Google Scholar
• Qiu W, Baccarelli A, Carey VJ et al. Variable DNA methylation is associated with chronic obstructive pulmonary disease and lung function. Am. J. Respir. Crit. Care Med. 185(4), 373–381 (2012).
   PubMed Web of Science ®Google Scholar
• Ko FW, Hui DS. Air pollution and chronic obstructive pulmonary disease. Respirology 17(3), 395–401 (2012).
   PubMed Web of Science ®Google Scholar
• Ristovski ZD, Miljevic B, Surawski NC et al. Respiratory health effects of diesel particulate matter. Respirology 17(2), 201–212 (2012).
   PubMed Web of Science ®Google Scholar
• Yang IA, Fong KM, Zimmerman PV, Holgate ST, Holloway JW. Genetic susceptibility to the respiratory effects of air pollution. Thorax 63(6), 555–563 (2008).
   PubMed Web of Science ®Google Scholar
• Holloway JW, Savarimuthu Francis S, Fong KM, Yang IA. Genomics and the respiratory effects of air pollution exposure. Respirology 17(4), 590–600 (2012).
   PubMed Web of Science ®Google Scholar
• Yang IA, Holz O, Jorres RA et al. Association of tumour necrosis factor-alpha polymorphisms and ozone-induced change in lung function. Am. J. Respir. Crit. Care Med. 171(2), 171–176 (2005).
   PubMed Web of Science ®Google Scholar
• Londahl J, Swietlicki E, Rissler J et al. Experimental determination of the respiratory tract deposition of diesel combustion particles in patients with chronic obstructive pulmonary disease. Part Fibre Toxicol. 9, 30 (2012).
   PubMed Web of Science ®Google Scholar
• Pezzulo AA, Starner TD, Scheetz TE et al. The air-liquid interface and use of primary cell cultures are important to recapitulate the transcriptional profile of in vivo airway epithelia. Am. J. Physiol. Lung Cell Mol. Physiol. 300(1), L25–L31 (2011).
   Web of Science ®Google Scholar
• Aufderheide M, Halter B, Mohle N, Hochrainer D. The CULTEX RFS: a comprehensive technical approach for the in vitro exposure of airway epithelial cells to the particulate matter at the air-liquid interface. Biomed. Res. Int. 2013, 734137 (2013).
   PubMed Web of Science ®Google Scholar
• Repapi E, Sayers I, Wain LV et al. Genome-wide association study identifies five loci associated with lung function. Nat. Genet. 42(1), 36–44 (2010).
   PubMed Web of Science ®Google Scholar
• Soler Artigas M, Loth DW, Wain LV et al. Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Nat. Genet. 43(11), 1082–1090 (2011).
   PubMed Web of Science ®Google Scholar
• Hansel N, Ruczinski I, Rafaels N et al. Genome-wide study identifies two loci associated with lung function decline in mild to moderate COPD. Hum. Genet. 132(1), 79–90 (2013).
   PubMed Web of Science ®Google Scholar
• Yang IA, Francis SM. Deconstructing COPD using genomic tools. Respirology 14(3), 313–317 (2009).
   PubMed Web of Science ®Google Scholar
• Savarimuthu Francis SM, Larsen JE, Pavey SJ et al. Expression profiling identifies genes involved in emphysema severity. Respir. Res. 10(1), 81 (2009).
   PubMedGoogle Scholar
• Savarimuthu Francis SM, Larsen JE, Pavey SJ et al. Genes and gene ontologies common to airflow obstruction and emphysema in the lungs of patients with COPD. PLoS ONE 6(3), e17442 (2011).
   PubMed Web of Science ®Google Scholar
• Yang IA, Clarke MS, Sim EH, Fong KM. Inhaled corticosteroids for stable chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 7, CD002991 (2012).
   PubMed Web of Science ®Google Scholar
• Steiling K, Van Den Berge M, Hijazi K et al. A dynamic bronchial airway gene expression signature of chronic obstructive pulmonary disease and lung function impairment. Am. J. Respir. Crit. Care Med. 187(9), 933–942 (2013).
   PubMed Web of Science ®Google Scholar
• Kitaguchi Y, Komatsu Y, Fujimoto K, Hanaoka M, Kubo K. Sputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthma. Int. J. Chron. Obstruct. Pulmon. Dis. 7, 283–289 (2012).
   PubMed Web of Science ®Google Scholar
• Nicholas BL. Search for biomarkers in chronic obstructive pulmonary disease: current status. Curr. Opin. Pulm. Med. 19(2), 103–108 (2013).
   PubMed Web of Science ®Google Scholar
• Warwick G, Thomas PS, Yates DH. Non-invasive biomarkers in exacerbations of obstructive lung disease. Respirology 18(5), 874–884 (2013).
   PubMed Web of Science ®Google Scholar
• Montuschi P, Collins JV, Ciabattoni G et al. Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am. J. Respir. Crit. Care Med. 162(3), 1175–1177 (2000).
   PubMed Web of Science ®Google Scholar
• Montuschi P. LC/MS/MS analysis of leukotriene B4 and other eicosanoids in exhaled breath condensate for assessing lung inflammation. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877(13), 1272–1280 (2009).
   PubMed Web of Science ®Google Scholar
• Liu SF, Wang CC, Chin CH, Chen YC, Lin MC. High value of combined serum C-reactive protein and BODE score for mortality prediction in patients with stable COPD. Arch. Bronconeumol. 47(9), 427–432 (2011).
   PubMed Web of Science ®Google Scholar
• Ju CR, Liu W, Chen RC. Serum surfactant protein D: biomarker of chronic obstructive pulmonary disease. Dis. Markers 32(5), 281–287 (2012).
   PubMed Web of Science ®Google Scholar
• De Laurentiis G, Paris D, Melck D et al. Separating smoking-related diseases using NMR-based metabolomics of exhaled breath condensate. J. Proteome Res. 12(3), 1502–1511 (2013).
   PubMed Web of Science ®Google Scholar
• Fens N, De Nijs SB, Peters S et al. Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD. Eur. Respir. J. 38(6), 1301–1309 (2011).
   PubMed Web of Science ®Google Scholar
• Bofan M, Mores N, Baron M et al. Within-day and between-day repeatability of measurements with an electronic nose in patients with COPD. J. Breath Res. 7(1), 017103 (2013).
   Web of Science ®Google Scholar
• Bozinovski S, Hutchinson A, Thompson M et al. Serum amyloid a is a biomarker of acute exacerbations of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 177(3), 269–278 (2008).
   PubMed Web of Science ®Google Scholar
• Tacon CE, Wiehler S, Holden NS, Newton R, Proud D, Leigh R. Human rhinovirus infection up-regulates MMP-9 production in airway epithelial cells via NF-{kappa}B. Am. J. Respir. Cell Mol. Biol. 43(2), 201–209 (2010).
   PubMed Web of Science ®Google Scholar
• Almansa R, Socias L, Andaluz-Ojeda D et al. Viral infection is associated with an increased proinflammatory response in chronic obstructive pulmonary disease. Viral Immunol. 25(4), 249–253 (2012).
   PubMed Web of Science ®Google Scholar
• Wu Q, Case SR, Minor MN et al. A novel function of MUC18: amplification of lung inflammation during bacterial infection. Am. J. Pathol. 182(3), 819–827 (2013).
   PubMed Web of Science ®Google Scholar
• Scherr A, Graf R, Bain M et al. Pancreatic stone protein predicts positive sputum bacteriology in exacerbations of COPD. Chest 143(2), 379–387 (2012).
   Web of Science ®Google Scholar
• Peng C, Tian C, Zhang Y, Yang X, Feng Y, Fan H. C-reactive protein levels predict bacterial exacerbation in patients with chronic obstructive pulmonary disease. Am. J. Med. Sci. 345(3), 190–194 (2013).
   PubMed Web of Science ®Google Scholar
• Tokman S, Schuetz P, Bent S. Procalcitonin-guided antibiotic therapy for chronic obstructive pulmonary disease exacerbations. Expert Rev. Anti .Infect .Ther. 9(6), 727–735 (2011).
   PubMed Web of Science ®Google Scholar
• Savarimuthu Francis SM, Tan ME, Fung PR et al. Peripheral compartment innate immune response to Haemophilus influenzae and Streptococcus pneumoniae in chronic obstructive pulmonary disease patients. Innate. Immun. 19(4), 428–437 (2012).
   PubMed Web of Science ®Google Scholar
• Wells JM, Washko GR, Han MK et al. Pulmonary arterial enlargement and acute exacerbations of COPD. N. Engl. J. Med. 367(10), 913–921 (2012).
   PubMed Web of Science ®Google Scholar
• Murphy PB, Kumar A, Reilly C et al. Neural respiratory drive as a physiological biomarker to monitor change during acute exacerbations of COPD. Thorax 66(7), 602–608 (2011).
   PubMed Web of Science ®Google Scholar
• Bafadhel M, Mckenna S, Terry S et al. Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial. Am. J. Respir. Crit. Care Med. 186(1), 48–55 (2012).
   PubMed Web of Science ®Google Scholar
• Wedzicha JA, Rabe KF, Martinez FJ et al. Efficacy of roflumilast in the chronic obstructive pulmonary disease frequent exacerbator phenotype. Chest 143(5), 1302–1311 (2012).
   Google Scholar
• Suissa S, Dell'aniello S, Ernst P. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax 67(11), 957–963 (2012).
   PubMed Web of Science ®Google Scholar
• Lee SJ, Lee SH, Kim YE et al. Clinical Features according to the Frequency of Acute Exacerbation in COPD. Tuberc. Respir. Dis. 72(4), 367–373 (2012).
   PubMedGoogle Scholar
• Hurst JR, Vestbo J, Anzueto A et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N. Engl. J. Med. 363(12), 1128–1138 (2010).
   PubMed Web of Science ®Google Scholar
• Duvoix A, Dickens J, Haq I et al. Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease. Thorax 68(7), 670–676 (2012).
   PubMed Web of Science ®Google Scholar
• Valipour A, Schreder M, Wolzt M et al. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease. Clin. Sci. (Lond.) 115(7), 225–232 (2008).
   PubMed Web of Science ®Google Scholar
• Agusti A, Edwards LD, Rennard SI et al. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS ONE 7(5), e37483 (2012).
   PubMed Web of Science ®Google Scholar
• Hodge S, Matthews G, Dean MM et al. Therapeutic role for mannose-binding lectin in cigarette smoke-induced lung inflammation? Evidence from a murine model. Am. J. Respir. Cell. Mol. Biol. 42(2), 235–242 (2010).
   PubMed Web of Science ®Google Scholar
• Yang IA, Seeney SL, Wolter JM et al. Mannose-binding lectin gene polymorphism predicts hospital admissions for COPD infections. Genes. Immun. 4, 269–274 (2003).
   PubMed Web of Science ®Google Scholar
• Lin CL, Siu LK, Lin JC et al. Mannose-binding lectin gene polymorphism contributes to recurrence of infective exacerbation in patients with COPD. Chest 139(1), 43–51 (2011).
   PubMed Web of Science ®Google Scholar
• Eagan TM, Aukrust P, Bakke PS et al. Systemic mannose-binding lectin is not associated with chronic obstructive pulmonary disease. Respir. Med. 104(2), 283–290 (2010).
   PubMed Web of Science ®Google Scholar
• Albert RK, Connett J, Curtis JL et al. Mannose-binding lectin deficiency and acute exacerbations of chronic obstructive pulmonary disease. Int. J. Chron. Obstruct. Pulmon. Dis. 7, 767–777 (2012).
   PubMed Web of Science ®Google Scholar
• Vanfleteren LEGW, Spruit MA, Groenen M et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 187(7), 728–735 (2013).
   PubMed Web of Science ®Google Scholar
• Divo M, Cote C, De Torres JP et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 186(2), 155–161 (2012).
   PubMed Web of Science ®Google Scholar
• Kessler R, Faller M, Weitzenblum E et al. "Natural history" of pulmonary hypertension in a series of 131 patients with chronic obstructive lung disease. Am. J. Respir. Crit. Care Med. 164(2), 219–224 (2001).
   PubMed Web of Science ®Google Scholar
• Shaw JG, Dent AG, Passmore LH et al. Genetic influences on right ventricular systolic pressure (RVSP) in chronic obstructive pulmonary disease (COPD). BMC Pulm. Med. 12, 25 (2012).
   PubMed Web of Science ®Google Scholar
• Castaldi PJ, Hersh CP, Reilly JJ, Silverman EK. Genetic associations with hypoxemia and pulmonary arterial pressure in COPD. Chest 135(3), 737–744 (2009).
   PubMed Web of Science ®Google Scholar
• Chaouat A, Savale L, Chouaid C et al. Role for interleukin-6 in COPD-related pulmonary hypertension. Chest 136(3), 678–687 (2009).
   PubMed Web of Science ®Google Scholar
• Wells JM, Washko GR, Han MK et al. Pulmonary arterial enlargement and acute exacerbations of COPD. N. Engl. J. Med. 367(10), 913–921 (2012).
   PubMed Web of Science ®Google Scholar
• Boschetto P, Beghe B, Fabbri LM, Ceconi C. Link between chronic obstructive pulmonary disease and coronary artery disease: implication for clinical practice. Respirology 17(3), 422–431 (2012).
   PubMed Web of Science ®Google Scholar
• Maclay JD, Macnee W. Cardiovascular disease in COPD: mechanisms. Chest 143(3), 798–807 (2013).
   PubMed Web of Science ®Google Scholar
• Macnee W, Maclay J, Mcallister D. Cardiovascular injury and repair in chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 5(8), 824–833 (2008).
   PubMedGoogle Scholar
• Barr RG, Ahmed FS, Carr JJ et al. Subclinical atherosclerosis, airflow obstruction and emphysema: the MESA Lung Study. Eur. Respir. J. 39(4), 846–854 (2012).
   PubMed Web of Science ®Google Scholar
• Mcallister DA, Maclay JD, Mills NL et al. Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 176(12), 1208–1214 (2007).
   PubMed Web of Science ®Google Scholar
• Lindberg A, Larsson LG, Muellerova H, Ronmark E, Lundback B. Up-to-date on mortality in COPD – report from the OLIN COPD study. BMC. Pulm. Med. 12, 1 (2012).
   PubMed Web of Science ®Google Scholar
• Arcari A, Magnacca S, Bracone F et al. Relation between pulmonary function and 10-year risk for cardiovascular disease among healthy men and women in Italy: the Moli-sani Project. Eur. J. Prev. Cardiol. 20(5), 862–871. (2012).
   PubMed Web of Science ®Google Scholar
• Feary JR, Rodrigues LC, Smith CJ, Hubbard RB, Gibson JE. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax 65(11), 956–962 (2010).
   PubMed Web of Science ®Google Scholar
• Calverley PM, Anderson JA, Celli B et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N. Engl. J. Med. 356(8), 775–789 (2007).
   PubMed Web of Science ®Google Scholar
• Tashkin DP, Celli B, Senn S et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N. Engl. J. Med. 359(15), 1543–1554 (2008).
   PubMed Web of Science ®Google Scholar
• Greenland P, Labree L, Azen SP, Doherty TM, Detrano RC. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA 291(2), 210–215 (2004).
   PubMed Web of Science ®Google Scholar
• Detrano R, Guerci AD, Carr JJ et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N. Engl. J. Med. 358(13), 1336–1345 (2008).
   PubMed Web of Science ®Google Scholar
• Shemesh J, Henschke CI, Shaham D et al. Ordinal scoring of coronary artery calcifications on low-dose CT scans of the chest is predictive of death from cardiovascular disease. Radiology 257(2), 541–548 (2010).
   PubMed Web of Science ®Google Scholar
• Ghoorah K, De Soyza A, Kunadian V. Increased cardiovascular risk in patients with chronic obstructive pulmonary disease and the potential mechanisms linking the two conditions: a review. Cardiol. Rev. (2012).
   Google Scholar
• Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. The Lancet 381(9868), 752–762 (2013).
   PubMed Web of Science ®Google Scholar
• Fried LP, Tangen CM, Walston J, Newman AB. Frailty in older adults: evidence for a phenotype. J. Gerontol. 56A(3), M146–M156 (2001).
   Google Scholar
• Waschki B, Kirsten A, Holz O et al. Physical activity is the strongest predictor of all-cause mortality in patients with copd: a prospective cohort study. CHEST J. 140(2), 331–342 (2011).
   PubMed Web of Science ®Google Scholar
• Collard RM, Boter H, Schoevers RA, Oude Voshaar RC. Prevalence of frailty in community-dwelling older persons: a systematic review. J. Am. Geriatr. Soc. 60(8), 1487–1492 (2012).
   PubMed Web of Science ®Google Scholar
• Buist AS, Mcburnie MA, Vollmer WM et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 370(9589), 741–750 (2007).
   PubMed Web of Science ®Google Scholar
• Hubbard RE, Andrew MK, Fallah N, Rockwood K. Comparison of the prognostic importance of diagnosed diabetes, co-morbidity and frailty in older people. Diab. Med. 27(5), 603–606 (2010).
   PubMed Web of Science ®Google Scholar
• Makary MA, Segev DL, Pronovost PJ et al. Frailty as a predictor of surgical outcomes in older patients. J. Am. Coll. Surg. 210(6), 901–908 (2010).
   PubMed Web of Science ®Google Scholar
• Singh M, Alexander K, Roger VL et al. Frailty and its potential relevance to cardiovascular care. Mayo Clin. Proc. 83(10), 1146–1153 (2008).
   PubMed Web of Science ®Google Scholar
• Galizia G, Cacciatore F, Testa G et al. Role of clinical frailty on long-term mortality of elderly subjects with and without chronic obstructive pulmonary disease. Aging Clin. Exp. Res. 23(2), 118–125 (2011).
   PubMed Web of Science ®Google Scholar
• Vaz Fragoso CA, Enright PL, Mcavay G, Van Ness PH, Gill TM. Frailty and respiratory impairment in older persons. Am. J. Med. 125(1), 79–86 (2012).
   PubMed Web of Science ®Google Scholar
• Yang IA, Relan V, Wright CM et al. Common pathogenic mechanisms and pathways in the development of COPD and lung cancer. Expert Opin. Ther. Targets 15(4), 439–456 (2011).
   PubMed Web of Science ®Google Scholar
• Houghton AM. Mechanistic links between COPD and lung cancer. Nat. Rev. Cancer 13(4), 233–245 (2013).
   PubMed Web of Science ®Google Scholar
• Smith BM, Pinto L, Ezer N, Sverzellati N, Muro S, Schwartzman K. Emphysema detected on computed tomography and risk of lung cancer: a systematic review and meta-analysis. Lung Cancer 77(1), 58–63 (2012).
   PubMed Web of Science ®Google Scholar
• Aberle DR, Adams AM, Berg CD et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N. Engl. J. Med. 365(5), 395–409 (2011).
   PubMed Web of Science ®Google Scholar
• Tammemagi MC, Katki HA, Hocking WG et al. Selection criteria for lung-cancer screening. N. Engl. J. Med. 368(8), 728–736 (2013).
   PubMed Web of Science ®Google Scholar
• Marshall HM, Bowman RV, Crossin J et al. Queensland lung cancer screening study: rationale, design and methods. Intern. Med. J .43(2), 174–182 (2013).
   PubMed Web of Science ®Google Scholar
• Tammemagi MC, Lam SC, Mcwilliams AM, Sin DD. Incremental value of pulmonary function and sputum DNA image cytometry in lung cancer risk prediction. Cancer Prev. Res. (Phila.) 4(4), 552–561 (2011).
   PubMed Web of Science ®Google Scholar
• Horvath I, Lazar Z, Gyulai N, Kollai M, Losonczy G. Exhaled biomarkers in lung cancer. Eur. Respir. J. 34(1), 261–275 (2009).
   PubMed Web of Science ®Google Scholar
• Collins PF, Elia M, Stratton RJ. Nutritional support and functional capacity in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respirology 18(4), 616–629 (2013).
   PubMed Web of Science ®Google Scholar
• Donaldson AV, Maddocks M, Martolini D, Polkey MI, Man WD. Muscle function in COPD: a complex interplay. Int. J. Chron. Obstruct. Pulmon. Dis. 7, 523–535 (2012).
   PubMed Web of Science ®Google Scholar
• Laurin C, Moullec G, Bacon SL, Lavoie KL. Impact of anxiety and depression on chronic obstructive pulmonary disease exacerbation risk. Am. J. Respir. Crit. Care Med. 185(9), 918–923 (2012).
   PubMed Web of Science ®Google Scholar
• Van De Bool C, Steiner MC, Schols AM. Nutritional targets to enhance exercise performance in chronic obstructive pulmonary disease. Curr. Opin. Clin. Nutr. Metab. Care 15(6), 553–560 (2012).
   PubMed Web of Science ®Google Scholar
• Wilk JB, Chen TH, Gottlieb DJ et al. A genome-wide association study of pulmonary function measures in the Framingham Heart Study. PLoS Genet. 5(3), e1000429 (2009).
   PubMed Web of Science ®Google Scholar
• Pillai SG, Ge D, Zhu G et al. A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet. 5(3), e1000421 (2009).
   PubMed Web of Science ®Google Scholar
• Cho MH, Boutaoui N, Klanderman BJ et al. Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nat. Genet. 42(3), 200–202 (2010).
   PubMed Web of Science ®Google Scholar
• Wilk JB, Shrine NR, Loehr LR et al. Genome-wide association studies identify CHRNA5/3 and HTR4 in the development of airflow obstruction. Am. J. Respir. Crit. Care Med. 186(7), 622–632 (2012).
   PubMed Web of Science ®Google Scholar
• Liu JZ, Tozzi F, Waterworth DM et al. Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nat. Genet. 42(5), 436–440 (2010).
   PubMed Web of Science ®Google Scholar
• The Tobacco and Genetics Consortium. Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nat. Genet. 42(5), 441–447 (2010).
   PubMed Web of Science ®Google Scholar
• Thorgeirsson TE, Gudbjartsson DF, Surakka I et al. Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nat. Genet. 42(5), 448–453 (2010).
   PubMed Web of Science ®Google Scholar
• Siedlinski M, Cho MH, Bakke P et al. Genome-wide association study of smoking behaviours in patients with COPD. Thorax 66(10), 894–902 (2011).
   PubMed Web of Science ®Google Scholar
• Milara J, Armengot M, Banuls P et al. Roflumilast N-oxide, a PDE4 inhibitor, improves cilia motility and ciliated human bronchial epithelial cells compromised by cigarette smoke in vitro. Br. J. Pharmacol. 166(8), 2243–2262 (2012).
   PubMed Web of Science ®Google Scholar
• Comer DM, Kidney JC, Ennis M, Elborn JS. Airway epithelial cell apoptosis and inflammation in COPD, smokers and nonsmokers. Eur. Respir. J. 41(5), 1058–1067 (2013).
   PubMed Web of Science ®Google Scholar
• Volckens J, Dailey L, Walters G, Devlin RB. Direct particle-to-cell deposition of coarse ambient particulate matter increases the production of inflammatory mediators from cultured human airway epithelial cells. Environ. Sci. Technol. 43(12), 4595–4599 (2009).
   PubMed Web of Science ®Google Scholar
• Li J, Ghio AJ, Cho SH, Brinckerhoff CE, Simon SA, Liedtke W. Diesel exhaust particles activate the matrix-metalloproteinase-1 gene in human bronchial epithelia in a beta-arrestin-dependent manner via activation of RAS. Environ. Health Perspect. 117(3), 400–409 (2009).
   PubMed Web of Science ®Google Scholar
• Jardim MJ, Fry RC, Jaspers I, Dailey L, Diaz-Sanchez D. Disruption of microRNA expression inhuman airway cells by diesel exhaust particles is linked to tumorigenesis-associated pathways. Environ. Health Perspect. 117(11), 1745–1751 (2009).
   PubMed Web of Science ®Google Scholar
• Hackett T-L, Singhera GK, Shaheen F et al. Intrinsic phenotypic differences of asthmatic epithelium and its inflammatory responses to respiratory syncytial virus and air pollution. Am. J. Respir. Cell. Mol. Biol. 45(5), 1090–1100 (2011).
   PubMed Web of Science ®Google Scholar
• Hyseni X, Soukup JM, Huang Y-CT. Pollutant particles induce arginase II in human bronchial epithelial cells. J. Toxicol. Environ. Health A 75(11), 624–636 (2012).
   PubMed Web of Science ®Google Scholar
• Hawley B, Volckens J. Proinflammatory effects of cookstove emissions on human bronchial epithelial cells. Indoor Air 23(1), 4–13 (2013).
   PubMed Web of Science ®Google Scholar